Biomodulatory therapy with low-dose azacitidine, pioglitazone and ATRA induces myeloid differentiation and phagocytosis in primary AML blasts

Klobuch, S. and Steinberg, T. and Reichle, A. and Herr, W. and Thomas, S. (2016) Biomodulatory therapy with low-dose azacitidine, pioglitazone and ATRA induces myeloid differentiation and phagocytosis in primary AML blasts. ONCOLOGY RESEARCH AND TREATMENT, 39 (Suppl3). p. 52. ISSN 2296-5270, 2296-5262

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Medicine > Zentren des Universitätsklinikums Regensburg > Regensburger Centrum für Interventionelle Immunologie (RCI)
Depositing User: Petra Gürster
Date Deposited: 27 Aug 2020 09:30
Last Modified: 27 Aug 2020 09:30
URI: https://pred.uni-regensburg.de/id/eprint/4174

Actions (login required)

View Item View Item